Profile
Xiao Bing Si worked as a Non-Executive Director at Immunotech Biopharm Ltd.
from 2019 to 2023.
Prior to that, he worked as an Engineer at Tianjin Boai NKY International Ltd.
from 2009 to 2012, and as an Assistant Manager at Beijing Zhong Shengbang New Materials Rsch Institute Co. Ltd.
from 2012 to 2013.
He also worked as a Project Manager at Peking University V-Ming Shanghai Investment Holdings Co. Ltd.
from 2014 to 2016, and as a Manager-Marketing Department at Beijing Huanuo Aomei Gene Biotechnology Co. Ltd.
from 2017 to 2018.
Mr. Si received his undergraduate degree from Shanxi University in 2003 and his graduate degree from Gansu College of Traditional Chinese Medicine in 2007.
Former positions of Xiao Bing Si
Companies | Position | End |
---|---|---|
IMMUNOTECH BIOPHARM LTD | Director/Board Member | 2023-08-24 |
Beijing Huanuo Aomei Gene Biotechnology Co. Ltd. | Sales & Marketing | 2018-02-28 |
Peking University V-Ming Shanghai Investment Holdings Co. Ltd. | Corporate Officer/Principal | 2016-10-31 |
Beijing Zhong Shengbang New Materials Rsch Institute Co. Ltd. | Corporate Officer/Principal | 2012-12-31 |
Tianjin Boai NKY International Ltd.
Tianjin Boai NKY International Ltd. Tianjin Boai NKY International Ltd. is headquartered in Tianjin, China. | Corporate Officer/Principal | 2011-12-31 |
Training of Xiao Bing Si
Shanxi University | Undergraduate Degree |
Gansu College of Traditional Chinese Medicine | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
IMMUNOTECH BIOPHARM LTD | Health Technology |
Private companies | 4 |
---|---|
Tianjin Boai NKY International Ltd.
Tianjin Boai NKY International Ltd. Tianjin Boai NKY International Ltd. is headquartered in Tianjin, China. | |
Beijing Zhong Shengbang New Materials Rsch Institute Co. Ltd. | |
Beijing Huanuo Aomei Gene Biotechnology Co. Ltd. | |
Peking University V-Ming Shanghai Investment Holdings Co. Ltd. |
- Stock Market
- Insiders
- Xiao Bing Si